The global Fertility Test Market size was valued at $462.23 million in 2020, and is projected to reach $842.96 million by 2028, registering a CAGR of 7.8%. Fertility testing is a medical and physical testing assessment that tests the ability to naturally conceive. Growing age is one of the factors that can affect fertility, so women and men who are 35 or older should consider fertility testing if they are unable to conceive even after six months of trying. The process of fertility testing involves the discussion of medical history, blood test, and minimally invasive procedures. It involves mainly the ovulation test by the detection of hormones such as luteinizing hormone or progesterone hormone in blood, urine, or saliva. The tests for men include semen analysis for normal sperm count.
Fertility test market growth is attributed to rise in the prevalence of diseases such as Polycystic Ovary Syndrome (PCOS) as women with the condition of PCOS do not ovulate each month regularly due to the overproduction of estrogen by the ovaries. Increase in the first-time pregnancies among women and declining fertility rates across the globe also drive the market growth. Furthermore, growth in awareness regarding fertility testing in both developed and developing countries boost the growth of the market. Nowadays, many companies and organizations arrange camps and annual events to raise awareness regarding fertility testing among individuals. Moreover, the launch of technologically advanced products and changes in lifestyle can result in increasing growth of fertility testing market. For instance, in June 2020, Modern Fertility launched the pregnancy and ovulation test kit. The company also launched a special app for it to centralize all fertility related data. The app helps in reading and tracking the test results, which is a broader push by the company to shift the fertility category into mainstream wellness. Similarly, in March 2020, Proov received an approval from the Food and Drug Administration (FDA) for its product at-home ovulation testing kit. This kit tests the presence of PdG, a urine metabolite of progesterone, which is a hormone released by the woman’s ovary after ovulation. In May 2019, Fertility Focus Limited launched the updated version of OvuSense app (OvuSense V.2.). It features the increased flexibility in data viewing and increased accuracy. However, unproven accuracy of ovulation monitors in PCOS/PCOD patients may restrain the fertility test market. According to the data of PCOS Awareness Association (PCOSAA), approximately 5 million of women have the polycystic ovarian syndrome in the U.S. The ovulation test kit may not give reliable results with the PCOS as the luteinizing hormone level or the estrogen hormone level is constantly high or multiple peaks can be seen. The results therefore can falsely reflect whether or not the female has ovulated. The ovulation prediction test cannot be considered accurate for checking the ovulation in such cases. This factor can hamper the growth of the fertility test market.
Moreover, increasing online sales of the fertility tests offers a great opportunity to the market players. The fertility testing devices can be bought from the nearby drug stores. These devices are available over-the-counter, which means they do not require prescription for buying. This makes it easier to market these products at online stores. There are several online platforms from where these products can be bought such as Amazon, Flipkart, and Walmart. The market players are also implementing strategies to sell the fertility testing devices online on the company website. They have started their private shopping website for their products. For instance, Modern Fertility company have started selling their products on their own shopping website. These types of strategies are anticipated to create lucrative opportunity for the growth of the fertility test market.
The global fertility test market is segmented on the basis of product, mode of purchase, application, end user, and region. By product, the market is divided into ovulation prediction kits, fertility monitors, and male fertility testing products. The fertility monitors segment is further divided into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. By mode of purchase, it is bifurcated into OTC-based and prescription-based. By application, it is bifurcated into female fertility testing and male fertility testing. By end user, it is divided into home care settings and hospitals/fertility clinics. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Product Type Segment Review
On the basis of product, the fertility test market is classified into ovulation prediction kit, fertility monitors, and male fertility testing products. The fertility monitors segment is further segmented into urine-based ovulation kits, saliva-based ovulation kits, and other fertility monitors. Ovulation prediction kits segment is the major contributor toward the market growth, owing to increase in the use of ovulation prediction kits and easy availability of over-the-counter test kits for at home testing.
By Product
Ovulation Prediction Kits segment holds a dominant position in 2020
Mode of Purchase Segment Review
On the basis of mode of purchase, the fertility test market is classified into OTC-based and prescription-based. The OTC-based segment is expected to dominate the fertility test market during the forecast year. The high growth and large share are attributed to the easy availability of the over-the-counter based kits for at-home fertility testing.
By Mode Of Purchase
OTC-based segment is projected as one of the most lucrative segment.
Application Segment Review
On the basis of application, the fertility test market is segmented into female fertility testing and male fertility testing. In this, the female fertility testing segment attributed for the larger market share due to the availability of the wide range of the fertility testing products for females, technologically advanced testing kits which predicts accurate ovulation date and decreasing female fertility rates.
End User Segment Review
On the basis of the end user, the fertility testing market is segmented into home care settings and fertility clinics. The home care settings is expected to dominate the fertility test market, owing to the shift in patients toward self-monitoring of healthcare conditions and easy availability of the user-friendly advantage of the at-home test products. For instance, the companies are launching the ovulation prediction kits that can be used at home to test the hormonal presence in the saliva or urine needed for the ovulation.
Region Segment Review
North America is constituted to have highest market share of fertility test market in 2020, followed by the other sectors. The larger share of the North America region can be attributed to the factors such as high prevalence of infertility and increase in awareness about fertility testing among the population and availability of the technologically advanced products. Overall, it is projected that the need for fertility testing in developing and developed regions of North America would rise sharply in the coming years.
By Region
Asia Pacific region would exhibit the highest CAGR of 5.7% during 2021-2028.
The key players operating in the global fertility test market include Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited, Geratherm Medical AG, HiLin Life Products Inc., Prestige Brands Holdings Inc., Quidel Corporation, Abbott Laboratories, UEBE Medical, and Advacare Pharma.
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current fertility test market trends and forecast estimations from 2020 to 2028, which assists to identify the prevailing market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2020 to 2028, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the market.
Key Market Segments
By Product
- Ovulation Prediction Kits
- Fertility Monitors
- Urine-based Ovulation Test Kits
- Saliva-based Ovulation Test Kits
- Other Fertility Monitors
- Male Fertility Test Kits
By Mode of Purchase
- OTC-based
- Prescription-based
By Application
- Female Fertility Testing
- Male Fertility Testing
By End User
- Home Care Settings
- Fertility Clinics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Church & Dwight Co. Inc.
- Fairhaven Health LLC
- Fertility Focus Limited
- Geratherm Medical AG
- HiLin Life Products Inc.
- Prestige Brands Holdings Inc.
- Quidel Corporation
- Abbott Laboratories
- UEBE Medical
- Advacare Pharma
Fertility Test Market Report Highlights
| Aspects | Details |
 By PRODUCT |
|
 By MODE OF PURCHASE |
|
 By APPLICATION |
|
 By Region |
|
 Key Market Players | AdvaCare Pharma, Quidel Corporation, Prestige Consumer Healthcare Inc. (Prestige Brands Holdings Inc.), Abbott Laboratories, Fertility Focus Limited, Fairhaven Health LLC, Hilin Life Products Inc., Geratherm Medical AG, UEBE Medical, Church & Dwight Co., Inc. |
Analyst Review
Fertility test is the most popular test for checking the infertility issues in the men and women. Rise in the prevalence of diseases such as PCOS, increases in the first-time pregnancies in women, decline in fertility rates across the globe, growth in awareness of fertility testing in both developed and developing countries, and launch of technologically advanced products with high accuracy are expected to propel the growth of the fertility test market during the forecast period. However, unproven accuracy of ovulation monitors in PCOS/PCOD patients and high cost of fertility testing monitors are expected to hinder the growth of the market. The ovulation prediction kits segment is expected to contribute major share toward the market growth, owing to increase in use of ovulation prediction kits and easy availability of the over-the-counter test kits for at-home testing.
The use of fertility test is highest in North America, owing to the factors such as high prevalence of infertility and growth in awareness regarding fertility testing among population and availability of technologically advanced products. Although the use of fertility test in LAMEA is low, the adoption rate is expected to increase, owing to rise in launch of new and advanced products with greater efficiency.
The total market value of Fertility Test Market is $ 462.2 million in 2020
The forecast period in the report is from 2021 to 2028
The market value of Fertility Test Market in 2028 was $ 842.9 Million
The base year for the report is 2020
Yes, Fertility Test Market companies are profiled in the report
The top companies that hold the market share in Fertility Test Market are Church & Dwight Co. Inc., Fairhaven Health LLC, Fertility Focus Limited and Geratherm Medical AG.
No, there is no value chain analysis provided in the Fertility Test Market report
The key trends in the Fertility Test Market are increase in the Polycystic Syndrome, rise in Technological advancements of products and surge in funding for development of new products
Loading Table Of Content...
